Intermediate oncological outcomes of percutaneous radiofrequency ablation for small renal tumors: Initial experience

Anticancer Research

Volumn 32, Issue 2, 2012, Pages 615-618

  Nitta, Yujiro ^a   Tanaka, Tomoaki ^a   Morimoto, Kazuya ^a   Makino, Tetsuya ^a   Nishikawa, Noriaki ^a   Tashiro, Kouichiro ^a   Naganuma, Toshihide ^a   Iguchi, Taro ^a   Matsuoka, Toshiyuki ^a   Nakatani, Tatsuya ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Kidney; Percutaneous; Radiofrequency ablation; Renal tumors; T1 stage

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; EVALUATION AND FOLLOW UP; HEMATOMA; HUMAN; KIDNEY ARTERY STENOSIS; KIDNEY CARCINOMA; NAUSEA AND VOMITING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECURRENCE FREE SURVIVAL; RETROPERITONEAL HEMORRHAGE; TUMOR VOLUME; URETER STRICTURE;

AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CATHETER ABLATION; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84863125222     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Gervais DA, McGovern FJ, Arellano RS, McDougal WS and Mueller PR: Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology 226: 417-424, 2003. (Pubitemid 36313429)
2. Lui KW, Gervais DA, Arellano RA and Mueller PR: Radiofrequency ablation of renal cell carcinoma. Clin Radiol 58: 905-913, 2003. (Pubitemid 37527146)
3. Arima K, Yamakado K, Kinbara H, Nakatsuka A, Takeda K and Sugimura Y: Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up. Int J Urol 14: 585-590, 2007. (Pubitemid 47084095)
4. McDougal WS, Gervais DA, McGovern FJ and Mueller PR: Long-term followup of patients with renal cell carcinoma treated with radio frequency ablation with curative intent. J Urol 174: 61-63, 2005. (Pubitemid 40825672)
5. Raman JD, Thomas J, Lucas SM, Bensalah K, Lotan Y, Trimmer C and Cadeddu JA: Radiofrequency ablation for T1a tumors in a solitary kidney: promising intermediate oncologic and renal function outcomes. Can J Urol 15: 3980-3985, 2008.
6. Zlotta AR, Wildschutz T, Raviv G, Peny MO, van Gansbeke D, Noel JC and Schulman CC: Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience. J Endourol 11: 251-258, 1997. (Pubitemid 27412203)
7. Levinson AW, Su LM, Agarwal D, Sroka M, Jarrett TW, Kavoussi LR and Solomon SB: Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass. J Urol 180: 499-504; discussion 504, 2008.
8. Mouraviev V, Joniau S, Van Poppel H and Polascik TJ: Current status of minimally invasive ablative techniques in the treatment of small renal tumours. Eur Urol 51: 328-336, 2007. (Pubitemid 44937810)
9. Park S, Anderson JK, Matsumoto ED, Lotan Y, Josephs S and Cadeddu JA: Radiofrequency ablation of renal tumors: intermediate-term results. J Endourol 20: 569-573, 2006. (Pubitemid 44689644)
10. Tracy CR, Raman JD, Donnally C, Trimmer CK and Cadeddu JA: Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years. Cancer 116: 3135-3142, 2010.
11. Stern JM, Svatek R, Park S, Hermann M, Lotan Y, Sagalowsky AI and Cadeddu JA: Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours. BJU Int 100: 287-290, 2007. (Pubitemid 47036574)
12. Crispen PL, Boorjian SA, Lohse CM, Sebo TS, Cheville JC, Blute ML and Leibovich BC: Outcomes following partial nephrectomy by tumor size. J Urol 180: 1912-1917, 2008.